Roots Analysis has announced the addition of “Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030” report to its list of offerings.
Harsimran Kaur, the principal analyst, stated, “Over 170 product candidates are under various stages of development for a range of back of the eye disorders. In the past few years, the market has witnessed emergence of several gene therapies, novel drug delivery systems and visual prostheses.”
The report presents opinions on several key aspects of the market. Among other elements, it includes:
Kaur further added, “In order to address concerns related to therapy administration, various companies have begun developing oral and topical drugs. Moreover, to improve compliance, several non-invasive delivery technologies are under development. The future holds significant promise for companies researching back of the eye disorders.”
The research covers detailed profiles and assesses product portfolios of the following companies:
For additional details, please visit https://www.rootsanalysis.com/reports/view_document/back-of-the-eye-disorders-novel-drugs-and-delivery-technologies-2017-2030/184.html
Contact:
Gaurav Chaudhary
Tel: +1-604-595-4954
Email: gaurav.chaudhary@rootsanalysis.com
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES